How Emergent BioSolutions Earned Profits But Delivered Disappointing Vaccine Returns
Emergent BioSolutions was awarded a $628 million federal contract with no competitive bidding. Top executives received big bonuses while factories mostly sat idle and tens of millions of Covid-19 doses were thrown away.
Source: NYT Health - Category: Consumer Health News Authors: Sharon LaFraniere, Chris Hamby and Rebecca R. Ruiz Tags: Emergent BioSolutions Inc Johnson & AstraZeneca PLC Government Contracts and Procurement Coronavirus (2019-nCoV) Vaccination and Immunization Health and Human Services Department Food and Drug Administration Kadlec, Robert P Trump, Don Source Type: news
More News: American Health | AstraZeneca | Bonuses | Contracts | Coronavirus | COVID-19 | Food and Drug Administration (FDA) | Government | Health | Trump | USA Health | Vaccines